MEDEXUS PHARMACEUTICALS INC

Versiunea din 21 septembrie 2024 18:10, autor: 127.0.0.1 (discuție) (The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).)

Pagina dedicata companiei MEDEXUS PHARMACEUTICALS INC listata cu simbolul CA.MDP

Descriere companie

Medexus Pharmaceuticals Inc. (https://www.medexus.com/en_US) is a Canada-based rare disease pharmaceutical company. The Company is a North American focused, specialty pharmaceutical business that operates through two divisions: Medexus Pharma Canada and Medexus Pharma USA. Medexus Pharma Canada, a fully integrated commercial infrastructure focused on rheumatology, allergy, auto-immune disease, specialty oncology and pediatric diseases in Canada. Medexus Pharma USA, a fully integrated commercial infrastructure focused on rheumatology and auto-immune diseases in the United States (U.S). The Company is focused on the therapeutic areas of auto-immune disease, hematology, pediatrics, dermatology and allergy. The Company's products are Rasuvo and Metoject, a formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases. It also offers IXINITY, a medicine for use in patients 12 years of age or older with Hemophilia B and Rupall, an allergy medication.

Grafic actiuni companie

Ultimele stiri despre MEDEXUS PHARMACEUTICALS INC (CA.MDP)